Fezolinetant HCl Size:10 mg solid Smiles: O=C1N=C(NS(=O)(=O)C2=CC=CC3=CC=CC=C32)S/C/1=C\C1C=CC(Br)=CC=1

Smiles: O=C1N=C(NS(=O)(=O)C2=CC=CC3=CC=CC=C32)S/C/1=C\C1C=CC(Br)=CC=1

Pretreatment of adipocytes with GF-109203X (5 microM) reduced GSK-3 activity in total cell lysates

2-dihydro-[3

AZD4205 is a selective JAK1 inhibitor

diC8) by 95%

Fezolinetant HCl Size:10 mg solid Smiles: O=C1N=C(NS(=O)(=O)C2=CC=CC3=CC=CC=C32)S/C/1=C\C1C=CC(Br)=CC=1Fezolinetant, also known as ESN 364, is Neurokinin 3 (NK 3) receptor antagonist which has been optimized for use in womens health, and is being developed for sex hormone related disorders such as endometriosis, polycystic ovarian syndrome and uterine fibroids. Fexolinetant allows modulation of the hypothalamic pituitary gonadal axis with a selective action on hormones relevant to disease. The agent is expected to have greater tolerability than